SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.40 |
| Enterprise Value ($M) | 17.85 |
| Book Value ($M) | -92.40 |
| Book Value / Share | -0.56 |
| Price / Book | -0.02 |
| NCAV ($M) | -92.49 |
| NCAV / Share | -1.02 |
| Price / NCAV | -0.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.06 |
| Current Ratio | 0.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.49 |
| Assets | 1.58 |
| Liabilities | 93.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -3.80 |
| Net Income | -9.48 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.18 |
| Cash from Investing | 0.00 |
| Cash from Financing | 3.40 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ayrton Capital LLC | 9.90 | 2.43 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| NXEN – Nexien BioPharma, Inc. | NYMXF – Nymox Pharmaceutical Corporation |
| OBSEF – ObsEva SA | ODTC – Odonate, Inc. |
| OMGAQ – Omega Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io